戻る Agendas
HTA AND ADAPTIVE PATHWAYS
Session Chair(s)
Sarah Garner, PHD
Acting Program Manager, Access to Medicines and Health Products
World Health Organization, Denmark
EMA Pilot on Adaptive Pathways: State of play
Speaker(s)
EMA Pilot on Adaptive Pathways: State of play
Francesca Cerreta, PHARMD, MPHARM, MS
European Medicines Agency, Netherlands
Principal Scientific Officer
HAS Perspective on Adaptive Pathways
François Meyer, MD
French National Authority for Health (HAS), France
Advisor to the President, International Affairs
Perspecitve from Industry
James Anderson
GlaxoSmithKline, United Kingdom
Head of Corporate Government Affairs